ArticleFrontiers in medicine2025
m6A-related genes of peripheral white blood cell in spinal cord injury as potential targets for prognosis and treatment.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Spinal cord injury (SCI) is a destructive neurological and pathological state that causes major motor, sensory, and autonomic dysfunction. N6-methyladenosine (m6A) is a reversible RNA modification implicated in various biological processes. However, few studies have examined m6A expression in patients with SCI. We explored the prognostic value of m6A-related genes as potential biomarkers in SCI to establish a set of accurate diagnostic and prognostic prediction models. Methods: Differentially expressed analysis and weighted gene co-expression network analysis (WGCNA) was used to explore m6a related modules and hub genes. KEGG and GO analyses was utilized to explore the potential role of these hub genes. Gene expression was verified in single-cell data. The correlation of m6A related gene with spinal cord injury severity was explored. Results: We found 289 SCI-related and five m6A-related candidate genes with high SCI correlation and high differential expression in the publicly available dataset, GSE151371. These genes are also involved in long-chain fatty acid binding. Early SCI was accompanied by significant immune cell infiltration. Simultaneously, infiltrating immune cells and the innate immune system have a strong cellular interaction, which gradually decreases over time. The number of PPARG-positive cells also increases after SCI. The comparatively higher expression of PPARG and lower expression of AK5 in white blood cells (WBCs) correlates with severity of SCI. Conclusion: Our integrated analysis illustrates the hub genes involved in SCI, which can be prognostic markers. Further understanding of the functions of the identified SCI hub genes may provide deeper insights into the molecular mechanisms of SCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.